ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.58
0.14%
US Tech 100
17,618.80
0.05%
S&P 500
5,187.70
0.13%
US Dollar vs CAD
1.37527
0.14%
Bitcoin
62,444.62
0.18%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Astrazeneca Plc (AZN)

  7. Astrazeneca Plc (AZN) News

AZN

Astrazeneca (AZN)

Astrazeneca Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AZN
DateTimeSourceHeadlineSymbolCompany
05/07/20241:00AMRNS Regulatory NewsAstraZeneca PLC AstraZeneca completes Cellectis equity investmentLSE:AZNAstrazeneca Plc
05/06/20241:46AMAlliance NewsAlliance NewsAstraZeneca completes collaboration and investment deal with CellectisLSE:AZNAstrazeneca Plc
05/06/20241:46AMAlliance NewsAlliance NewsAstraZeneca completes collaboration and investment deal with CellectisLSE:AZNAstrazeneca Plc
05/02/20244:04AMAlliance NewsAlliance NewsAstraZeneca notes positive trial results for Calquence treatmentLSE:AZNAstrazeneca Plc
05/02/20244:04AMAlliance NewsAlliance NewsAstraZeneca notes positive trial results for Calquence treatmentLSE:AZNAstrazeneca Plc
05/02/20241:00AMRNS Regulatory NewsAstraZeneca PLC Calquence combination improved PFS in 1L MCLLSE:AZNAstrazeneca Plc
05/01/20249:00AMRNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
04/29/20243:13AMAlliance NewsAlliance NewsAstraZeneca makes progress with Truqap and Enhertu cancer treatmentsLSE:AZNAstrazeneca Plc
04/29/20243:13AMAlliance NewsAlliance NewsAstraZeneca makes progress with Truqap and Enhertu cancer treatmentsLSE:AZNAstrazeneca Plc
04/29/20241:05AMRNS Regulatory NewsAstraZeneca PLC Truqap recommended for EU breast cancer approvalLSE:AZNAstrazeneca Plc
04/29/20241:00AMRNS Regulatory NewsAstraZeneca PLC Enhertu improved PFS in HER2-low and ultralowLSE:AZNAstrazeneca Plc
04/25/20247:00AMPR Newswire (US)AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingLSE:AZNAstrazeneca Plc
04/25/20243:18AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growthLSE:AZNAstrazeneca Plc
04/25/20243:18AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growthLSE:AZNAstrazeneca Plc
04/25/20241:00AMRNS Regulatory NewsAstraZeneca PLC 1st Quarter ResultsLSE:AZNAstrazeneca Plc
04/24/20244:32AMAlliance NewsAlliance NewsAngle shares jump on supplier agreement with with AstraZenecaLSE:AZNAstrazeneca Plc
04/24/20244:32AMAlliance NewsAlliance NewsAngle shares jump on supplier agreement with with AstraZenecaLSE:AZNAstrazeneca Plc
04/16/20245:38AMAlliance NewsAlliance NewsIN THE KNOW: Deutsche ups AstraZeneca as higher payout addresses worryLSE:AZNAstrazeneca Plc
04/16/20245:38AMAlliance NewsAlliance NewsIN THE KNOW: Deutsche ups AstraZeneca as higher payout addresses worryLSE:AZNAstrazeneca Plc
04/16/20242:39AMAlliance NewsAlliance NewsAstraZeneca's hails Imfinzi survival data on cancer formLSE:AZNAstrazeneca Plc
04/16/20242:39AMAlliance NewsAlliance NewsAstraZeneca's hails Imfinzi survival data on cancer formLSE:AZNAstrazeneca Plc
04/11/202411:42AMAlliance NewsAlliance News*AstraZeneca AGM resolutions pass, but 36% vote against remuneration policyLSE:AZNAstrazeneca Plc
04/11/202411:42AMAlliance NewsAlliance News*AstraZeneca AGM resolutions pass, but 36% vote against remuneration policyLSE:AZNAstrazeneca Plc
04/11/202411:30AMRNS Regulatory NewsAstraZeneca PLC Result of AGMLSE:AZNAstrazeneca Plc
04/11/20242:56AMAlliance NewsAlliance NewsTOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023LSE:AZNAstrazeneca Plc
04/11/20242:56AMAlliance NewsAlliance NewsTOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023LSE:AZNAstrazeneca Plc
04/11/20241:00AMRNS Regulatory NewsAstraZeneca PLC AstraZeneca increases 2024 dividend by 7%LSE:AZNAstrazeneca Plc
04/08/20242:36AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca hails neurological data for Ultomiris, SolirisLSE:AZNAstrazeneca Plc
04/08/20242:36AMAlliance NewsAlliance NewsTOP NEWS: AstraZeneca hails neurological data for Ultomiris, SolirisLSE:AZNAstrazeneca Plc
04/08/20241:00AMRNS Regulatory NewsAstraZeneca PLC Enhertu approved in US for HER2+ solid tumoursLSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN

Your Recent History

USOTC
MONI
Moon Equity (PK)
USOTC
GSTC
Globestar Therapeutics (PK)
USOTC
INKW
Greene Concepts (PK)
USOTC
WDLF
Decentral Life (PK)
NASDAQ
HOLO
MicroCloud Hologram
USOTC
TSOI
Therapeutic Solutions (PK)
USOTC
RXMD
Progressive Care (QB)
USOTC
HMBL
HUMBL (PK)
USOTC
AXXA
Exxe (PK)
USOTC
IQST
iQSTEL (QX)
USOTC
CLNV
Clean Vision (QB)
NASDAQ
FCEL
FuelCell Energy
USOTC
CYDY
CytoDyn (QB)
NYSE
GME
GameStop
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
TPTW
TPT Global Tech (CE)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved